Executive Summary
Immunodiagnostic Systems Limited (IDS) is a dynamic SME dedicated to the development and provision of innovative assays for use in clinical and research laboratories worldwide. From a modest Sales and Distribution operation established in 1977, IDS has become not only a developer and manufacturer in its own right, but also nurtures technology development externally, in British universities and research institutes. The Company is focussed on sustaining its position as a fully integrated In Vitro Diagnostics (IVD) company, building and maintaining capability in de novo product design, development, manufacture and global marketing.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
